Home › Funds › VAUGHAN DAVID INVESTMENTS LLC/IL › ABT

VAUGHAN DAVID INVESTMENTS LLC/IL position in ABT

ABBOTT LABORATORIES · Health Care

VAUGHAN DAVID INVESTMENTS LLC/IL reported holding 455,795 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$45.0M, representing 0.97% of its reported portfolio and ranking #46 among its reported holdings. VAUGHAN DAVID INVESTMENTS LLC/IL has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)455.80K sh
Reported value held$45.05M
Portfolio Weight0.97%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How VAUGHAN DAVID INVESTMENTS LLC/IL's ABT position evolved

VAUGHAN DAVID INVESTMENTS LLC/IL first disclosed a stake in ABT in Q3 2023 at 418,615 shares (US$40.5M). The position peaked in Q2 2025 at 421,288 shares, worth US$57.3M. Across 13 filings, VAUGHAN DAVID INVESTMENTS LLC/IL increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 455,795 shares valued at US$45.0M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 418.62K $40.54M New
Q4 2023 423.18K $46.58M Add
Q1 2024 424.87K $48.29M Hold
Q2 2024 427.25K $44.40M Add
Q3 2024 431.46K $49.19M Add
Q4 2024 434.06K $49.10M Add
Q1 2025 424.32K $56.29M Reduce
Q2 2025 421.29K $57.30M Reduce
Q3 2025 417.17K $55.88M Reduce
Q4 2025 417.34K $52.29M Hold
Q1 2026 426.86K $43.83M Add
Q2 2026 457.32K $41.50M Add
Q3 2026 455.80K $45.05M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has VAUGHAN DAVID INVESTMENTS LLC/IL held ABT?

VAUGHAN DAVID INVESTMENTS LLC/IL has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is VAUGHAN DAVID INVESTMENTS LLC/IL's current position in ABT?

As of Q3 2026, VAUGHAN DAVID INVESTMENTS LLC/IL holds 455.80K shares of ABT (ABBOTT LABORATORIES), valued at $45.05M, representing 0.97% of its reported portfolio and ranking #46.

Has VAUGHAN DAVID INVESTMENTS LLC/IL been buying or selling ABT?

In the latest 13F filing (Q3 2026), VAUGHAN DAVID INVESTMENTS LLC/IL held unchanged its position in ABT. The position peaked in Q2 2025 at 421.29K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.